S230815 Solution for injection 10mg/ml
CL1-230815-001
Phase 2 small_molecule active
Quick answer
S230815 Solution for injection 10mg/ml for KCNT1-related Developmental and Epileptic Encephalopathy is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- KCNT1-related Developmental and Epileptic Encephalopathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active